Ultrastructural and immunocytochemical analyses of opioid treatment effects on PC3 prostatic cancer cells

✍ Scribed by Beatrice Baldelli; Lorella Vecchio; Marco Biggiogera; Emanuela Vittoria; Giovanni Muzzonigro; Giancarlo Gazzanelli; Manuela Malatesta

• Book ID: 102889523
• Publisher: John Wiley and Sons
• Year: 2004
• Tongue: English
• Weight: 767 KB
• Volume: 64
• Category: Article
• ISSN: 1059-910X
• DOI: 10.1002/jemt.20077

✦ Synopsis

Abstract

Some opioid peptides are able to inhibit the growth of human prostatic cancer cells; in particular, the [D‐Ala^2^,D‐Leu^5^] enkephalin (DADLE) reduces PC3 cell growth. In order to understand how DADLE decreases cell proliferation, we investigated, by electron microscopy, its effects on PC3 cellular components. PC3 cells were incubated with DADLE and processed for both ultrastructural morphology and immunoelectron microscopy. Some cells were incubated with BrU to determine the transcriptional rate. BrU and DADLE molecules were detected by immunogold techniques and the labeling was quantitatively evaluated. Modifications of some cytoplasmic and nuclear components were observed in DADLE‐treated cells. Moreover, treated cells incorporated lower amounts of BrU than control cells. DADLE molecules were located in the cytoplasm and in the nucleus, especially on mRNA transcription and early splicing sites. Our data suggest that DADLE is able to slow down the synthetic activity of PC3 cells, perhaps interfering with nuclear functions. Microsc. Res. Tech. 64:243–249, 2004. © 2004 Wiley‐Liss, Inc.